Navigation Links
For the First Time, a Glioma ¨C Brain Cancer ¨C may be Eliminated by a Chinese Research/Medical Team, Using a Novel Stem Cell Based Therapy of Cellonis Biotech, Beijing
Date:12/17/2009

BEIJING, Dec. 17 /PRNewswire-Asia/ -- Using a novel stem cell based technology of Cellonis Biotechnologies, Beijing, a Chinese research/medical team may eliminate a glioma -- brain cancer -- of a 36 year old Norwegian patient in a hospital in Beijing. The treatment shows that the activated immune system can directly kill tumor stem cells as well as cancer daughter cells. The amazing outcome of this novel treatment within a Comprehensive Cancer Therapy tells Cellonis that the future vaccination therapies may be targeted towards cancer stem cell lysates to improve the antigen-presenting Dendritic Cell response.

(Photo: http://www.newscom.com/cgi-bin/prnh/20091217/CNTH007)

Arve Johnsen, 36, from Norway, a patient diagnosed with glioma in 2006 and relapsed in 2009 after surgical resection. He arrived in Beijing in August 2009 with his wife Vanja and a one-year-old daughter, with the hope that the doctors in Norway were wrong. They told the family there is no other option anymore in the Scandinavian countries or in Europe for Arve to control the progress of disease and prolong his life. Driven by the hope that their daughter could grow up with a father, the Johnsen family started a research campaign to find other treatments worldwide, to give Arve a new hope.

Comprehensive Cancer Therapy in China

The Johnsen's, having heard about the sustainable success of a Comprehensive Cancer Therapy (CCT) in China, decided to try for this last chance in a country 10,000 km away from Norway. This kind of CCT had been developed in the past few years by a Chinese team of scientific researchers and clinical doctors in Beijing, combining conventional canc
'/>"/>

SOURCE Cellonis Biotechnologies
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
3. Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend
4. Genmab Announces 2007 First Half Year Results
5. Pharsight Achieves First License Sale for Public-Source Database
6. Novare Announces First Ever Single Port Laparoscopic Kidney Removal (Nephrectomy) Using RealHand(TM) HD Instruments
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. China Medical Technologies Reports First Quarter Financial Results
9. Pressure BioSciences, Inc. Issued First Patent in Canada
10. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
11. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... AMSTERDAM , June 29, 2015 ... technical and medical information products and services, today announced ... 2014. According to the 2014 Journal Citation Reports® (JCR) ... journal Impact Factors increase from 2013 to 2014, ahead ... journals occupied the top rank in 62 subject categories, ...
(Date:6/26/2015)... Kan. , June 26, 2015 /PRNewswire/ ... PETX ), a pet therapeutics company focused ... innovative biopharmaceutical products for companion animals, today ... effectiveness study of capromorelin (AT-002), the company,s ... Capromorelin is a small molecule that mimics ...
(Date:6/26/2015)... ... 2015 , ... Charm Sciences, Inc. is pleased to announce ... (GIPSA) awarded a five year contract to Charm Sciences to monitor Deoxynivalenol (DON), ... Test. This 5 minute quantitative test extracts DON from samples using water. , ...
(Date:6/26/2015)... NEW YORK and MUMBAI, India ... (TCS), (BSE: 532540, NSE: TCS) a leading global IT ... has been designated as a Leader in Worldwide Life ... IDC, in the " IDC MarketScape: Worldwide Life Science ... 2015) report. The report evaluated eight ...
Breaking Biology Technology:Elsevier Announces 2014 Citation Impact Highlights 2Elsevier Announces 2014 Citation Impact Highlights 3Aratana Therapeutics Announces Positive Pivotal Results for AT-002 2Aratana Therapeutics Announces Positive Pivotal Results for AT-002 3Aratana Therapeutics Announces Positive Pivotal Results for AT-002 4Aratana Therapeutics Announces Positive Pivotal Results for AT-002 5USDA-GIPSA (FGIS) Awards 5 Year Contract for Vomitoxin Tests to Charm Sciences 2TCS Recognized as a Leader in Life Sciences R&D Risk-Based Monitoring by IDC MarketScape 2TCS Recognized as a Leader in Life Sciences R&D Risk-Based Monitoring by IDC MarketScape 3TCS Recognized as a Leader in Life Sciences R&D Risk-Based Monitoring by IDC MarketScape 4
... TNGN ), a leader in regenerative medicine, today ... on Wednesday, October 27, 2010 in New York, New York. ... product development portfolio and upcoming corporate milestones, and will expand ... The live webcast of the event will be available ...
... Calif., Oct. 12 With more than 200 ... Workshop, Microsoft Research showcases two technologies that facilitate ... a MODISAzure-based environmental service. (Logo: ... Programmers and developers in bioscience now ...
... The Ontario Institute for Cancer Research (OICR) today announced ... Inc., an Ontario company that is developing a software ... detailed disease and treatment data without compromising individual privacy. ... Assessment Tool (PARAT), is currently being used by hospitals ...
Cached Biology Technology:Tengion Announces Webcast of Analyst and Investor Meeting on October 27, 2010 2Microsoft Research Makes Microsoft Biology Foundation and MODISAzure-Based Environmental Service Available to Scientists and Researchers 2Microsoft Research Makes Microsoft Biology Foundation and MODISAzure-Based Environmental Service Available to Scientists and Researchers 3Microsoft Research Makes Microsoft Biology Foundation and MODISAzure-Based Environmental Service Available to Scientists and Researchers 4OICR Makes Equity Investment in Medical Information Company 2
(Date:6/18/2015)... June 18, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market announces that its Wocket® ... on "Money on the Mark", scheduled to air on WABC ... June 20 th . The broadcast air- ... 7:00 to 8:00pm EST. NXT-ID, Inc.,s CEO Gino Pereira ...
(Date:6/17/2015)... JOSE, Calif. , June 17, 2015 /PRNewswire/ ... in human interface solutions, today announced that Xiaomi, ... adopted the Synaptics ® ClearPad ® ... of display driver integrated circuits (DDICs) for its ... Pro. By leveraging ClearPad for full in-cell display ...
(Date:6/16/2015)... NEW YORK , June 16, 2015  With ... the world, security remains a top concern. The recent ... confirms the need for strong authentication within government ... HYPR Token, a biometric one-time password (OTP) authenticator, has ... Processing Standards (FIPS) 140-2 Level 3 validation for tamper ...
Breaking Biology News(10 mins):NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 3Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 2Government Ready Biometric Security Approaching as HYPR Corp. Files FIPS 140-2 Level 3 Validation for Its Proprietary Biometric Token 3
... , SANTA ANA, Calif. and ... Microsystems, Inc., d.b.a. Identive Group (Nasdaq: INVE ; Frankfurt ... for the security, identification and RFID industries, today announced that ... three new executives in line with the announced reorganization of ...
... 2010 The Translational Genomics Research Institute (TGen) today ... agreement with the Van Andel Research Institute (VARI) that ... TGen expects the agreement to create a ... and treatments for patient benefit. ...
... Medicine believe they may have discovered how the hormone ... findings will be presented at the Annual Scientific Meeting ... by Errol Norwitz, M.D., professor in the Department of ... Preterm birthdelivery prior to 37 weeks gestationhas become increasingly ...
Cached Biology News:Identive Group Expands Executive Management Team 2Identive Group Expands Executive Management Team 3TGen finalizes alliance with Van Andel Research Institute 2TGen finalizes alliance with Van Andel Research Institute 3
... PTOs are internucleotide modifications, where one ... replaced by a sulphur atom. This modification ... are available as Full-PTOs ... with thio-caps Several internucleotide ...
... The VARIOKLAV 75 S and 135 S steam ... double bottoms combine the advantages of a double-walled ... use, effective deaeration and drying by built-in jacket ... - fast cooling. The chamber is free of ...
Request Info...
... catalyzes the transfer of the gamma-phosphate ... single- and double-stranded DNA, RNA, and ... the 3'-phosphate from 3'-phosphoryl polynucleotides, deoxyribonucleoside ... form a 3'-hydroxyl group. Storage Buffer: ...
Biology Products: